Maciej Banach: Navigating Therapeutic Complexity in Cardiometabolic Disease Prevention
Maciej Banach, Chief Medical Officer at Graylight Imaging, Visiting Senior Research Fellow at Liverpool Centre for Cardiovascular Science, Adjunct Professor at The Johns Hopkins University School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Progress in Cardiovascular Diseases, adding:
“See our recent paper on a critically important topic: how to deliver effective CVD prevention for patients with multimorbidity and multiple concurrent risk factors, each often requiring several interventions or medications (oral, subcutaneous) with different dosing schedules.
In other words: how can we achieve effective, patient-centered CVD prevention overall after successfully managing individual risk factors?
‘The goal of modern cardiometabolic medicine should be maximal clinical benefit through minimal therapeutic friction (complex regimens, side-effects, monitoring requirements, adherence, high costs, limited access, etc.).
Only by aligning our rapid pace of innovation with the pragmatic constraints of real world care can we ensure that the ‘era of polypharmacy’ leads to better outcomes rather than just more prescriptions.'”
Title: Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies
Authors: Yashendra Sethi, Kunal Mahajan, Michael D. Shapiro, Maciej Banach

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience